The group's principal activities are to discover, develop and commercialization of innovative pharmaceutical compounds. The pharmaceutical compounds are directed towards serving unmet medical needs. The group's drug development program has yielded an extensive portfolio of pharmaceutical compounds for treatment in two major therapeutic areas, respiratory and central nervous system disorders. The group has operations in the United States and Canada.
